68
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Prolyl-4-Hydroxylase α Subunit 2 as a Novel Potential Biomarker for Predicting the Prognosis of Epithelial Ovarian Carcinoma

ORCID Icon &
Pages 4455-4462 | Published online: 03 Jun 2021

References

  • Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277–300. doi:10.3322/caac.2007320610543
  • Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol. 2006;20(2):207–225. doi:10.1016/j.bpobgyn.2005.10.00716359925
  • Armstrong DK. Relapsed ovarian cancer: challenges and management strategies for a chronic disease. Oncologist. 2002;7(Suppl 5):20–28. doi:10.1634/theoncologist.7-suppl_5-20
  • Lan C, Li Y, Liu J. Intraperitoneal access via direct puncture is an alternative way to deliver intraperitoneal chemotherapy in ovarian, fallopian tube and primary peritoneal cancer. Gynecol Oncol. 2009;114(1):42–47. doi:10.1016/j.ygyno.2009.03.03419398124
  • Anuradha S, Webb PM, Blomfield P, et al. Survival of Australian women with invasive epithelial ovarian cancer: a population-based study. Med J Aust. 2014;201(5):283–288. doi:10.5694/mja14.0013225163381
  • Myllyharju J. Prolyl 4-hydroxylases, the key enzymes of collagen biosynthesis. Matrix Biol. 2003;22(1):15–24. doi:10.1016/S0945-053X(03)00006-412714038
  • Atkinson A, Renziehausen A, Wang H, et al. Collagen prolyl hydroxylases are bifunctional growth regulators in melanoma. J Invest Dermatol. 2019;139(5):1118–1126. doi:10.1016/j.jid.2018.10.03830452903
  • Cao Y, Han Q, Li J, Jia Y, Zhang R, Shi H. P4HA2 contributes to cervical cancer progression via inducing epithelial-mesenchymal transition. J Cancer. 2020;11(10):2788–2799. doi:10.7150/jca.3840132226497
  • Feng GX, Li J, Yang Z, et al. Hepatitis B virus X protein promotes the development of liver fibrosis and hepatoma through downregulation of miR-30e targeting P4HA2 mRNA. Oncogene. 2017;36(50):6895–6905. doi:10.1038/onc.2017.29128846110
  • Pankova D, Jiang Y, Chatzifrangkeskou M. RASSF1A controls tissue stiffness and cancer stem-like cells in lung adenocarcinoma. EMBO J. 2019;38(13):e100532. doi:10.15252/embj.201810053231268606
  • Xiong G, Deng L, Zhu J, Rychahou PG, Xu R. Prolyl-4-hydroxylase α subunit 2 promotes breast cancer progression and metastasis by regulating collagen deposition. BMC Cancer. 2014;14:1. doi:10.1186/1471-2407-14-124383403
  • Gong W, Ni M, Chen Z, Zheng Z. Expression and clinical significance of methyl-CpG binding domain protein 2 in high-grade serous ovarian cancer. Oncol Lett. 2020;20(3):2749–2756.32782591
  • Hendrix ND, Wu R, Kuick R, Schwartz DR, Fearon ER, Cho KR. Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas. Cancer Res. 2006;66(3):1354–1362. doi:10.1158/0008-5472.CAN-05-369416452189
  • Adib TR, Henderson S, Perrett C, et al. Predicting biomarkers for ovarian cancer using gene-expression microarrays. Br J Cancer. 2004;90(3):686–692. doi:10.1038/sj.bjc.660160314760385
  • Gyorffy B, Lánczky A, Szállási Z. Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients. Endocr Relat Cancer. 2012;19(2):197–208. doi:10.1530/ERC-11-032922277193
  • Cress RD, Chen YS, Morris CR, Petersen M, Leiserowitz GS. Characteristics of long-term survivors of epithelial ovarian cancer. Obstet Gynecol. 2015;126(3):491–497. doi:10.1097/AOG.000000000000098126244529
  • Henderson BE, Feigelson HS. Hormonal carcinogenesis. Carcinogenesis. 2000;21(3):427–433. doi:10.1093/carcin/21.3.42710688862
  • Liu L, Wang X, Li X, Wu X, Tang M, Wang X. Upregulation of IGF1 by tumor-associated macrophages promotes the proliferation and migration of epithelial ovarian cancer cells. Oncol Rep. 2018;39(2):818–826. doi:10.3892/or.2017.614829251331
  • Liu Y, Wang Y, Yao D, Cui D. LncSOX4 serves an oncogenic role in the tumorigenesis of epithelial ovarian cancer by promoting cell proliferation and inhibiting apoptosis. Mol Med Rep. 2018;17(6):8282–8288. doi:10.3892/mmr.2018.889229693704
  • Akahane T, Hirasawa A, Tsuda H, et al. The origin of stroma surrounding epithelial ovarian cancer cells. Int J Gynecol Pathol. 2013;32(1):26–30. doi:10.1097/PGP.0b013e318251853323202778
  • Ghinea N. Vascular endothelial FSH receptor, a target of interest for cancer therapy. Endocrinology. 2018;159(9):3268–3274. doi:10.1210/en.2018-0046630113652
  • Girigoswami K, Saini D. Extracellular matrix remodeling and development of cancer. Stem Cell Rev Rep. 2020;1–9. doi:10.1007/s12015-019-09951-x31907765
  • Walker C, Mojares E, Del Río Hernández A. Role of extracellular matrix in development and cancer progression. Int J Mol Sci. 2018;19(10). doi:10.3390/ijms19103028
  • Chen D, Chen G, Jiang W, et al. Association of the collagen signature in the tumor microenvironment with lymph node metastasis in early gastric cancer. JAMA Surg. 2019;154(3):e185249. doi:10.1001/jamasurg.2018.524930698615
  • Tameda M, Sugimoto K, Shiraki K, et al. Collagen triple helix repeat containing 1 is overexpressed in hepatocellular carcinoma and promotes cell proliferation and motility. Int J Oncol. 2014;45(2):541–548. doi:10.3892/ijo.2014.244524841500